Bezlotoxumab in Patients with a Primary <i>Clostridioides difficile</i> Infection: A Literature Review
Background: Nowadays, one of the main issues in the management of <i>Clostridioides difficile</i> infection (CDI) is the high rate of recurrences (rCDI), causing increased mortality and higher health care costs. Objectives: To assess the available evidence on the use of bezlotoxumab for...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-10-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/11/11/1495 |